Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter study of sofosbuvir/ledipasvir ± ribavirin in chronic genotype 1 hepatitis C virus infection
2014-001245-24Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ledipasvir in hepatitis C virus infection (2 arms), sponsored by Gilead Sciences. Primary endpoint: SVR12. Started Jul 2014; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2014-001245-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001245-24.